港股异动 | 耐世特(1316.HK)大涨近10% 股价创17个月新高
格隆汇12月9日丨耐世特(1316.HK)涨幅扩大至9.59%,报9.14港元创17个月新高价,10月以来累计升幅达60%。暂成交1.37亿港元,总市值229.19亿港元。昨日耐世特亚太区精益学院在苏州盛大开业,标志着耐世特亚太区在核心工程、智能制造和精益生产体系三方面布局的全面建立。此外,耐世特日前与大陆的合资公司开发制动转向技术,为自动驾驶汽车提供安全冗余。 国元国际此前表示,公司2020H2-2021年有望持续复苏。同时认为公司深耕转向系统领域近百年,先发优势明显,客户基础深厚,具备较宽的护城河。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.